MACROGENICS INC — Director's Dealing 2022

May 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2022-05-16

Reporting Person: Koenig Scott (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-16	Common Stock	M	53265	$1.51	Acquired	1049636	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-16	Employee stock option (right to buy)	$1.51	M	53265	Disposed	2023-01-05	Common Stock (53265.0)	Direct

Footnotes

F1: The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse.

F2: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.